Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nan Niu

Showing results (101-110 of 115) with videos related to

Pageof 12
Sort By:
Journal of Hematology & Oncology|March 29, 2022
Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognosesTao Xia, Keyu Li, Nan Niu, et al.
Elife|July 28, 2025
Efficacy and safety of neoadjuvant stereotactic body radiation therapy plus dalpiciclib and exemestane for hormone receptor-positive, HER2-negative breast cancer: A prospective pilot studyYu Zhang, Shuo Cao, Nan Niu, et al.
Elife|December 22, 2023
Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot studyGuanglei Chen, Xi Gu, Jinqi Xue, et al.
The Journal of Experimental Medicine|April 11, 2022
CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinomaJianxin Wang, May Tun Saung, Keyu Li, et al.
The Lancet Regional Health. Western Pacific|October 13, 2025
Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trialJinqi Xue, Huilian Shan, Fang Qiu, et al.
Journal of Hematology & Oncology|August 7, 2024
Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administrationKeyu Li, Junke Wang, Rui Zhang, et al.
Journal of Clinical Medicine|February 11, 2023
Can Measuring the 'Dual Anchors of Aorta' Enhance the Success Rate of TAVR?-A Single-Center ExperienceYang Chen, Md Misbahul Ferdous, Lakshme Kottu, et al.
Medcomm|March 12, 2024
A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple-positive breast cancerShiwen Huo, Jinqi Xue, Shuo Wang, et al.
Gastroenterology|June 19, 2022
Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 TherapyAlex B Blair, Jianxin Wang, John Davelaar, et al.
Nature Biotechnology|October 9, 2018
Comprehensive identification of peptides in tandem mass spectra using an efficient open search engineHao Chi, Chao Liu, Hao Yang, et al.
Pageof 12

Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Journal of Hematology & Oncology|March 29, 2022
Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognosesTao Xia, Keyu Li, Nan Niu, et al.
Elife|July 28, 2025
Efficacy and safety of neoadjuvant stereotactic body radiation therapy plus dalpiciclib and exemestane for hormone receptor-positive, HER2-negative breast cancer: A prospective pilot studyYu Zhang, Shuo Cao, Nan Niu, et al.
Elife|December 22, 2023
Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot studyGuanglei Chen, Xi Gu, Jinqi Xue, et al.
The Journal of Experimental Medicine|April 11, 2022
CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinomaJianxin Wang, May Tun Saung, Keyu Li, et al.
The Lancet Regional Health. Western Pacific|October 13, 2025
Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trialJinqi Xue, Huilian Shan, Fang Qiu, et al.
Journal of Hematology & Oncology|August 7, 2024
Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administrationKeyu Li, Junke Wang, Rui Zhang, et al.
Journal of Clinical Medicine|February 11, 2023
Can Measuring the 'Dual Anchors of Aorta' Enhance the Success Rate of TAVR?-A Single-Center ExperienceYang Chen, Md Misbahul Ferdous, Lakshme Kottu, et al.
Medcomm|March 12, 2024
A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple-positive breast cancerShiwen Huo, Jinqi Xue, Shuo Wang, et al.
Gastroenterology|June 19, 2022
Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 TherapyAlex B Blair, Jianxin Wang, John Davelaar, et al.
Nature Biotechnology|October 9, 2018
Comprehensive identification of peptides in tandem mass spectra using an efficient open search engineHao Chi, Chao Liu, Hao Yang, et al.
Pageof 12